Posts by: Jose Lopes

News

Protagonist Therapeutics has begun dosing patients in a Phase 1 clinical trial of an oral ulcerative colitis (UC) treatment candidate known as PN-10943, the company announced in a press release. PN-10943 ... Read more

November 12, 2018November 12, 2018

FDA Approves Humira Biosimilar Hyrimoz for Treatment of IBD, Other Conditions

News

The U.S. Food and Drug Administration (FDA) approved Hyrimoz (adalimumab-adaz, by Sandoz), a biosimilar to AbbVie’s Humira (adalimumab) for the treatment of Crohn’s disease (CD) in adults and ulcerative colitis (UC). A ... Read more

September 26, 2018

Olorinab Eases Abdominal Pain Associated with Crohn’s Disease in Phase 2a Trial

News

Olorinab, an investigational compound being developed by Arena Pharmaceuticals, significantly reduced chronic abdominal pain in patients with Crohn’s disease, according to topline results from a Phase 2a clinical trial. The findings ... Read more

September 19, 2018September 19, 2018

Most IBD Specialists Support Continuing IBD Meds When Traveling to Areas With TB

News

About two-thirds of inflammatory bowel disease (IBD) specialists worldwide support continuing IBD medications when traveling to tuberculosis (TB)-endemic areas, while about half offer pre-travel advice. The data also show ... Read more

September 11, 2018September 11, 2018

Fecal Microbiota Transplant May Effectively Treat IBD, but More Research Needed, Review Study Says

News

Treating inflammatory bowel disease (IBD) with fecal microbiota transplant (FMT) shows potential, but longer clinical trials and more information on the best method of delivery, the risks, and the best ... Read more

July 25, 2018July 25, 2018

Vegetables, Whole Grains, Fruit, Beans Lower Risk of IBD, Study Suggests

News

Eating vegetables and whole grains reduces the risk of Crohn’s disease, while eating more fruit and beans/legumes lowers the risk of ulcerative colitis (UC), according to researchers in Canada. In ... Read more

July 20, 2018July 20, 2018

Mental Health of Priority in Treating IBD Patients Due to Possibly Higher Suicide Risk, Study Says

News

People with inflammatory bowel disease (IBD) may be at a higher risk of suicide than those without this disorder, according to a study by researchers in Canada. Their findings ... Read more

July 6, 2018July 6, 2018

Finalists Announced for UnitedHealth and Lyfebulb’s IBD-related Innovation Challenge

News

Lyfebulb and UnitedHealth Group have selected the 11 finalists for their innovation challenge, which will reward the most innovative solutions to help patients with inflammatory bowel disease (IBD). These contestants ... Read more

July 2, 2018July 2, 2018

Byproduct of Cholesterol Metabolism May Activate Gut Immune Cells to Cause IBD, Study Says

News

A cholesterol metabolite — a byproduct of cholesterol metabolism — triggers an abnormal immune response in inflammatory bowel disease (IBD) further aggravating such diseases, researchers found in a mouse ... Read more

June 20, 2018June 20, 2018

Patient Concerns Over Effects of IBD Therapies on Reproductive Health Not Adequately Addressed, Study Reports

News

Women’s concerns over taking inflammatory bowel disease (IBD) medications during their reproductive years are not being satisfactorily addressed by physicians, according to a study that analyzed relevant social media ... Read more

Posts by: Jose Lopes

Jose Lopes

Protagonist Therapeutics Starts Phase 1 Trial of Potential Ulcerative Colitis Treatment PN-10943

FDA Approves Humira Biosimilar Hyrimoz for Treatment of IBD, Other Conditions

Olorinab Eases Abdominal Pain Associated with Crohn’s Disease in Phase 2a Trial

Most IBD Specialists Support Continuing IBD Meds When Traveling to Areas With TB

Fecal Microbiota Transplant May Effectively Treat IBD, but More Research Needed, Review Study Says

Vegetables, Whole Grains, Fruit, Beans Lower Risk of IBD, Study Suggests

Mental Health of Priority in Treating IBD Patients Due to Possibly Higher Suicide Risk, Study Says

Finalists Announced for UnitedHealth and Lyfebulb’s IBD-related Innovation Challenge

Byproduct of Cholesterol Metabolism May Activate Gut Immune Cells to Cause IBD, Study Says

Pin It on Pinterest